GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soleno Therapeutics Inc (FRA:6XC) » Definitions » Cyclically Adjusted FCF per Share

Soleno Therapeutics (FRA:6XC) Cyclically Adjusted FCF per Share : €-24.34 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Soleno Therapeutics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Soleno Therapeutics's adjusted free cash flow per share for the three months ended in Sep. 2024 was €-0.325. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-24.34 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-01-18), Soleno Therapeutics's current stock price is €44.06. Soleno Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was €-24.34. Soleno Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Soleno Therapeutics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Soleno Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soleno Therapeutics Cyclically Adjusted FCF per Share Chart

Soleno Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -40.54 -21.05

Soleno Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.41 -21.05 -34.33 -28.35 -24.34

Competitive Comparison of Soleno Therapeutics's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Soleno Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soleno Therapeutics's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soleno Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Soleno Therapeutics's Cyclically Adjusted Price-to-FCF falls into.



Soleno Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Soleno Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.325/133.0289*133.0289
=-0.325

Current CPI (Sep. 2024) = 133.0289.

Soleno Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -14.022 99.070 -18.828
201503 -17.989 99.621 -24.022
201506 -19.794 100.684 -26.153
201509 -20.231 100.392 -26.808
201512 -18.182 99.792 -24.238
201603 -18.249 100.470 -24.163
201606 -17.372 101.688 -22.726
201609 -11.829 101.861 -15.448
201612 -11.934 101.863 -15.585
201703 -6.021 102.862 -7.787
201706 -4.200 103.349 -5.406
201709 -2.657 104.136 -3.394
201712 -2.991 104.011 -3.825
201803 -1.570 105.290 -1.984
201806 -1.736 106.317 -2.172
201809 -1.605 106.507 -2.005
201812 -2.182 105.998 -2.738
201903 -1.546 107.251 -1.918
201906 -1.629 108.070 -2.005
201909 -1.981 108.329 -2.433
201912 -1.663 108.420 -2.040
202003 -1.719 108.902 -2.100
202006 -1.883 108.767 -2.303
202009 -0.986 109.815 -1.194
202012 -1.062 109.897 -1.286
202103 -1.184 111.754 -1.409
202106 -1.251 114.631 -1.452
202109 -0.865 115.734 -0.994
202112 -1.143 117.630 -1.293
202203 -1.083 121.301 -1.188
202206 -0.468 125.017 -0.498
202209 -0.499 125.227 -0.530
202212 -0.514 125.222 -0.546
202303 -0.665 127.348 -0.695
202306 -0.493 128.729 -0.509
202309 -0.519 129.860 -0.532
202312 -0.183 129.419 -0.188
202403 -0.319 131.776 -0.322
202406 -0.425 132.554 -0.427
202409 -0.325 133.029 -0.325

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Soleno Therapeutics  (FRA:6XC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Soleno Therapeutics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Soleno Therapeutics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Soleno Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
203 Redwood Shores Parkway, Suite 500, Redwood City, CA, USA, 94065
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

Soleno Therapeutics Headlines

No Headlines